Bioadaptives (BDPT) Preferred Shares (2021 - 2026)

Bioadaptives has disclosed Preferred Shares across 6 years of filings, most recently posting $27.0 for Q1 2026.

• Preferred Shares for Q1 2026 came in at $27.0, up 285.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.0 (up 285.71% YoY), and the FY2025 annual result was $100.0, up 9900.0% from the prior year.
• Preferred Shares came in at $27.0 for Q1 2026 at Bioadaptives, down from $100.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $335.0 in Q1 2024 to a low of $1.0 in Q4 2023.
• The 5-year median for Preferred Shares is $100.0 (2024), against an average of $108.31.
• Peak annual rise in Preferred Shares reached 9900.0% in 2025, while the deepest fall reached 99.66% in 2025.
• Bioadaptives' Preferred Shares stood at $160.0 in 2022, then sank by 99.38% to $1.0 in 2023, then changed by 0.0% to $1.0 in 2024, then jumped by 9900.0% to $100.0 in 2025, then sank by 73.0% to $27.0 in 2026.
• The last three Preferred Shares figures came in at $27.0 (Q1 2026), $100.0 (Q4 2025), and $1.0 (Q3 2025), per Business Quant data.